Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

The Rigenera method improved hair thickness and reduced hair loss in patients.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Vitamin-D and calcium effectively treat hair loss in children.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Combining FCS and MPG is more effective for treating stable vitiligo than using either alone.

Redensyl, saw palmetto, and biotin with platelet-rich plasma is a better treatment for hair loss than Procapil with platelet-rich plasma.

Rapamycin-primed exosomes can significantly boost hair regrowth.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Verilich serum effectively and safely improves hair loss treatment.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Combining PRP with follicular transplantation improves vitiligo treatment better than follicular transplantation alone.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

LGD1069 effectively prevents breast tumors in mice without toxicity.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Bortezomib chemotherapy can cause temporary skin rashes.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.